Long-Acting Injectables (LAIs) Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecules, Biologics), By Route of Administration (Intramuscular, Subcutaneous), By Therapeutic Area (Central Nervous System Disorders, Infectious Diseases, Metabolic & Endocrine Disorders, Oncology, Autoimmune & Inflammatory Diseases, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Specialty Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 04, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
  7. North America Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  8. Europe Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. France
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  9. APAC Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. China
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. India
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  10. Middle East and Africa Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  11. LATAM Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  12. Competitive Landscape
    1. Long-Acting Injectables (LAIs) Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Johnson & Johnson (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amgen Inc. (US)
    3. Pfizer Inc. (US)
    4. AbbVie Inc. (US)
    5. AstraZeneca PLC (UK)
    6. Sanofi S.A. (France)
    7. Novartis AG (Switzerland)
    8. Novo Nordisk A/S (Denmark)
    9. GSK plc (UK)
    10. Lilly (US)
    11. Gilead Sciences, Inc. (US)
    12. Teva Pharmaceutical Industries Ltd. (Israel)
    13. Otsuka Pharmaceutical Co., Ltd. (Japan)
    14. Reddy's Laboratories Ltd. (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Long-Acting Injectables (LAIs) Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 3: Global Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 4: Global Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 5: Global Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 6: North America Long-Acting Injectables (LAIs) Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 7: North America Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 8: North America Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 9: North America Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 10: North America Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 11: U.S. Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 12: U.S. Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 13: U.S. Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 14: U.S. Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 15: Canada Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 16: Canada Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 17: Canada Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 18: Canada Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 19: Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 20: Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 21: Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 22: Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 23: Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 24: U.K. Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 25: U.K. Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 26: U.K. Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 27: U.K. Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Germany Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 29: Germany Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 30: Germany Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 31: Germany Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 32: France Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 33: France Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 34: France Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 35: France Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 36: Spain Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 37: Spain Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 38: Spain Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 39: Spain Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 40: Italy Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 41: Italy Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 42: Italy Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 43: Italy Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 44: Russia Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 45: Russia Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 46: Russia Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 47: Russia Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 48: Nordic Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 49: Nordic Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 50: Nordic Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 51: Nordic Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 52: Benelux Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 53: Benelux Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 54: Benelux Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 55: Benelux Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Rest of Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 57: Rest of Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 58: Rest of Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 59: Rest of Europe Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 60: APAC Long-Acting Injectables (LAIs) Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 61: APAC Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 62: APAC Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 63: APAC Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 64: APAC Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 65: China Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 66: China Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 67: China Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 68: China Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 69: Korea Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 70: Korea Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 71: Korea Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 72: Korea Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 73: Japan Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 74: Japan Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 75: Japan Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 76: Japan Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 77: India Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 78: India Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 79: India Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 80: India Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: Australia Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 82: Australia Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 83: Australia Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 84: Australia Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 85: Taiwan Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 86: Taiwan Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 87: Taiwan Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 88: Taiwan Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 89: South East Asia Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 90: South East Asia Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 91: South East Asia Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 92: South East Asia Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 93: Rest of Asia-Pacific Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 94: Rest of Asia-Pacific Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 95: Rest of Asia-Pacific Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 96: Rest of Asia-Pacific Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 97: Middle East and Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 98: Middle East and Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 99: Middle East and Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 100: Middle East and Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 101: Middle East and Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 102: UAE Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 103: UAE Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 104: UAE Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 105: UAE Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 106: Turkey Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 107: Turkey Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 108: Turkey Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 109: Turkey Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 110: Saudi Arabia Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 111: Saudi Arabia Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 112: Saudi Arabia Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 113: Saudi Arabia Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 114: South Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 115: South Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 116: South Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 117: South Africa Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 118: Egypt Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 119: Egypt Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 120: Egypt Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 121: Egypt Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 122: Nigeria Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 123: Nigeria Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 124: Nigeria Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 125: Nigeria Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 126: Rest of MEA Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 127: Rest of MEA Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 128: Rest of MEA Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 129: Rest of MEA Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 130: LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 131: LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 132: LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 133: LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 134: LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 135: Brazil Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 136: Brazil Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 137: Brazil Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 138: Brazil Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 139: Mexico Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 140: Mexico Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 141: Mexico Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 142: Mexico Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 143: Argentina Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 144: Argentina Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 145: Argentina Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 146: Argentina Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 147: Chile Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 148: Chile Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 149: Chile Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 150: Chile Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 151: Colombia Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 152: Colombia Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 153: Colombia Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 154: Colombia Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 155: Rest of LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Molecule Type - 2022-2034 (USD Billion)

Table 156: Rest of LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 157: Rest of LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Therapeutic Area - 2022-2034 (USD Billion)

Table 158: Rest of LATAM Long-Acting Injectables (LAIs) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: